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Methods
• Allows for tissue specificity via UAS (we are using UAS that are only expressed in wings and 
thorax)
• Temperature sensitive; higher temperature leads to higher expression
• Overexpression mimics oncogene inducing mutations, creating an artificial oncogene
• Using  Immunofluorescence to track proteins indicative of characteristics of cancer cells; 
(i.e. DCP-1 stain for apoptosis and E-cadherin stain for migration)
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Question
Background
• Cancer cells are characterized by six hallmarks: evading apoptosis, resistant to 
anti-growth signaling, sustaining proliferative signaling, inducing angiogenesis, 
divisional immortality, and tissue invasion 6
• Cancer cells have higher levels of ROS due to an increased metabolic rate 5
• The role of Src in cancer has long been unclear as overexpression of Src has 
been shown to lead to apoptosis in addition to proliferative effects 1
• Increased levels of Src activation with high levels of ROS could be changing 
proliferation rate, evading apoptosis as a form of organismal compensation for 
increased proliferation, or inhibiting cellular migration as a form of organismal 
compensation
Conclusion
Overgrowth phenotypes seen in adult ↑Src ↑ROS wings do not 
appear to reflect less apoptosis or organismal compensation as 
apoptosis does not vary between ↑Src  and ↑Src ↑ROS wing 
discs (Figure 4) and the addition of DIAP does not increase tissue 
size (Figure 5). E-cadherin staining did not demonstrate differences 
in localization or intensity between ↑Src and ↑Src ↑ROS and 
controls (data not shown), indicating that migration does not play 
a significant role in tumorgenesis. Instead, the data suggests that 
↑Src ↑ROS combination is impacting proliferation rates.
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Figure 2. Formation and functions of Reactive Oxygen Species. Under normal 
conditions, high levels of ROS leads to apoptosis whereas at lower levels, ROS are 
regulated by antioxidants and function in cellular signaling that can promote cell survival 
and proliferation. By increasing antioxidants, cancer cells can balance higher levels of 
ROS, to induce higher levels of cell signaling and proliferation, but avoid apoptosis (red 
arrow). 
Figure 3. UAS-GAL4 system. 
The UAS line has the gene of 
interest under the control of 
the UAS while the Gal4 line 
generates the promoter to 
increase expression of genes 
under the control of the UAS. 
When the two parental lines 
are crossed, one with UAS 
and the other with GAL4, 
GAL4 will interact with the 
UAS and activate Src (UASSrc) 
expression and/or increase 
ROS levels (UASCncCRNAi). 
Results
How does the combination of Src and ROS 
promote tumorigenesis?
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Figure 4. Increased size and apoptotic activity at 25ºC and 18ºC in Larval Drosophila 
wing disc. Larval wing discs were dissected and stained to investigate general wing disc 
size (DAPI) and apoptosis activity (DCP-1) (Figure 4A). Both ↑Src and ↑Src, ↑ROS were 
found to be larger than either control (p<0.05) at both 25ºC and 18ºC. There was no 
statistical difference between ↑Src and ↑Src, ↑ROS  due to wing disc size. Both ↑Src and 
↑Src, ↑ROS were also found to have a higher proportion of caspase activity than either 
control (p<0.05). There was no statistical difference between ↑Src and ↑Src, ↑ROS  due to 
apoptosis activity (Figure 4B)
Cancer is fast becoming the largest global disease burden, affecting 
millions of people across the world. The oncogene Src has been 
implicated in breast and colon cancers as well as melanomas.1Src is 
related to cell-to-cell adhesion and is regulated by reactive oxygen 
species (ROS).2,3 ROS are highly reactive compounds produced via 
cellular metabolism and are used for cellular signaling can cause 
cellular damage at high levels.4,5 High levels of Src activation and ROS 
leads to a the formation of a tumor in the Drosophila melonogaster
but it is unclear what mechanisms allow this to happen. 
Figure 1. ROS changes phenotype of Src overexpression. ↑Src by itself does not 
produce a notable phenotype, with either increased levels of proliferation or migration 
leading to organismal compensation which prevents a notable phenotype. ↑Src + 
↑ROS however could change either Src expression or organismal compensation.
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Figure 5. Posterior wing compartment size differences in adult 
Drosophila. Src and ROS were expressed in posterior adult wing 
compartments (Figure 5A). Adult Drosophila wing anterior and posterior 
compartments were compared to identify size differences (Figure 5B). 
DIAP indicated inhibition of apoptosis. ↑Src ↑ROS was larger than the 
control (engal) (p<0.05) but was not significantly larger than ↑Src . 73% 
of ↑Src and 78% of ↑Src ↑ROS demonstrated cross vein overgrowth as 
compared to the 0% of the ↑Src +DIAP and ↑Src ↑ROS +DIAP wings.
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